Literature DB >> 11259122

Differential expression and distribution of alpha-, beta-, and gamma-synuclein in the developing human substantia nigra.

J E Galvin1, T M Schuck, V M Lee, J Q Trojanowski.   

Abstract

Although the functions of alpha-, beta-, and gamma-synuclein (alphaS, betaS, gammaS, respectively) are unknown, these synaptic proteins are implicated in the pathogenesis of Parkinson's disease (PD) and related disorders. For example, alphaS forms Lewy bodies (LBs) in substantia nigra (SN) neurons of PD. However, since it is not known how these hallmark PD lesions contribute to the degeneration of SN neurons or what the normal function of alphaS is in SN neurons, we studied the developing human SN from 11 weeks gestational age (GA) to 16 years of age using immunohistochemistry and antibodies to alphaS, betaS, gammaS, other synaptic proteins, and tyrosine hydoxylase (TH). SN neurons expressed TH at 11 weeks GA and alphaS, betaS, and gammaS appeared initially at 15, 17, and 18 weeks GA, respectively. These synucleins first appeared in perikarya of SN neurons after synaptophysin, but about the same time as synaptotagmin and synaptobrevin. Redistribution of alphaS from perikarya to processes of SN neurons occurred by 18 weeks GA in parallel with synaptophysin, while betaS and synaptotagmin were redistributed similarly between 20 and 28 weeks GA and this also occurred with gammaS and synaptobrevin between 33 weeks GA and 9 months postnatal. These data suggest that alphaS, betaS, and gammaS may play a functional role in the development and maturation of SN neurons, but it remains to be determined how sequestration of alphaS as LBs in PD contributes to the degeneration of SN neurons.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259122     DOI: 10.1006/exnr.2000.7615

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  27 in total

Review 1.  Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets.

Authors:  Ying C Li; Ege T Kavalali
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

2.  Complex Effects of the ZSCAN21 Transcription Factor on Transcriptional Regulation of α-Synuclein in Primary Neuronal Cultures and in Vivo.

Authors:  Georgia Dermentzaki; Nikolaos Paschalidis; Panagiotis K Politis; Leonidas Stefanis
Journal:  J Biol Chem       Date:  2016-02-23       Impact factor: 5.157

Review 3.  Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.

Authors:  Carmen Noelker; Harald Hampel; Richard Dodel
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

Review 4.  Cell Biology and Pathophysiology of α-Synuclein.

Authors:  Jacqueline Burré; Manu Sharma; Thomas C Südhof
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

5.  Determining nuclear localization of alpha-synuclein in mouse brains.

Authors:  Z Huang; Z Xu; Y Wu; Y Zhou
Journal:  Neuroscience       Date:  2011-10-19       Impact factor: 3.590

6.  The function of α-synuclein.

Authors:  Jacob T Bendor; Todd P Logan; Robert H Edwards
Journal:  Neuron       Date:  2013-09-18       Impact factor: 17.173

Review 7.  Alpha-synuclein and dopamine metabolism.

Authors:  Shun Yu; Kenji Uéda; Piu Chan
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

8.  Alpha-synuclein promotes early neurite outgrowth in cultured primary neurons.

Authors:  Guangwei Liu; Peng Wang; Xin Li; Yaohua Li; Shengli Xu; Kenji Uéda; Piu Chan; Shun Yu
Journal:  J Neural Transm (Vienna)       Date:  2013-02-27       Impact factor: 3.575

9.  Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression.

Authors:  Klára Kitajka; Andrew J Sinclair; Richard S Weisinger; Harrison S Weisinger; Michael Mathai; Anura P Jayasooriya; John E Halver; László G Puskás
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

10.  Alpha-synuclein alters Notch-1 expression and neurogenesis in mouse embryonic stem cells and in the hippocampus of transgenic mice.

Authors:  Leslie Crews; Hideya Mizuno; Paula Desplats; Edward Rockenstein; Anthony Adame; Christina Patrick; Beate Winner; Juergen Winkler; Eliezer Masliah
Journal:  J Neurosci       Date:  2008-04-16       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.